From: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
Study procedures | Molecular profiling D1 | W16a | Survival FU |
---|---|---|---|
Informed consent for molecular profiling | X | ||
Check inclusion criteria and exclusion criteria for molecular profiling | X | ||
ECOG PS | X | ||
Survivala | X | X | Through cancer registry |
QoLa | X | X | |
Central lab sampling | X | ||
Tumor biopsy | X | ||
Plasma /serum samples | X |